Advertisement
Screener

Twist Bioscience Corporation (TWST) Auditor

Twist Bioscience Corporation Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2025-11-17: Fiscal year end 2025-09-30; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2024-11-18: Fiscal year end 2024-09-30; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2023-11-21: Fiscal year end 2023-09-30; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2023-06-05: Fiscal year end 2022-09-30; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2025-11-172025-09-30Ernst & Young LLP42San Mateo, CaliforniaYes
2024-11-182024-09-30Ernst & Young LLP42San Mateo, CaliforniaYes
2023-11-212023-09-30Ernst & Young LLP42San Mateo, CaliforniaYes
2023-06-052022-09-30Ernst & Young LLP42San Mateo, CaliforniaYes
2022-11-282022-09-30Ernst & Young LLP42San Mateo, CaliforniaYes
2021-11-232021-09-30PricewaterhouseCoopers LLPSan Jose, CaliforniaYes
2020-11-272020-09-30PricewaterhouseCoopers LLPSan Jose, California
2019-12-132019-09-30PricewaterhouseCoopers LLPSan Jose, California
2018-12-202018-09-30PricewaterhouseCoopers LLPSan Jose, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78